HENDERSON JANE (Chief Financial Officer) sold 1.1% of their position (2K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $170.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/28/2026ACC: 0001104659-26-036332
Officer· Chief Financial Officer
Since Mar 2026
-2K
Net shares
Net seller
$170.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2K
Price / share
$85.00
Trade value
$170K
% of position
1.1%
3/25/2026
181.37K→179.37K
Total
Net shares
−2K
Net value
-$170K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/25/2026 | S · Sale | −2K | $85.00 | $170K | 1.1% | 181.37K | 179.37K |
| Total | −2K | -$170K | ||||||
Derivative Transactions0
No derivative transactions reported